Ascletis Pharma Inc (2VJ) — Strategic Asset Allocation Index
Ascletis Pharma Inc (2VJ) has a Strategic Asset Allocation Index of 2.5% as of June 2023. Strategic assets (PP&E of €64.99 Million plus long-term investments of €-) total €64.99 Million, measured against net assets of €2.57 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Ascletis Pharma Inc (2VJ) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Ascletis Pharma Inc Strategic Asset Allocation Index (2016–2022)
This chart shows how Ascletis Pharma Inc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 2.5%, representing strategic assets of €64.99 Million against net assets of €2.57 Billion EUR. For live market cap and overall valuation, see 2VJ company net worth.
Annual Strategic Asset Allocation Index for Ascletis Pharma Inc (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Ascletis Pharma Inc from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Ascletis Pharma Inc's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 2.8% | €71.83 Million | €71.83 Million | €- | €2.54 Billion | ▼ 0.0 pp |
| 2021 | 2.8% | €77.51 Million | €77.51 Million | €- | €2.73 Billion | ▲ +0.0 pp |
| 2020 | 2.8% | €84.58 Million | €84.58 Million | €- | €2.98 Billion | ▼ -0.1 pp |
| 2019 | 3.0% | €98.73 Million | €98.73 Million | €- | €3.32 Billion | ▲ +0.4 pp |
| 2018 | 2.6% | €88.33 Million | €88.33 Million | €- | €3.43 Billion | ▼ -6.5 pp |
| 2017 | 9.1% | €78.81 Million | €78.81 Million | €- | €869.83 Million | ▼ -3.1 pp |
| 2016 | 12.2% | €49.83 Million | €49.83 Million | €- | €409.08 Million | — |